Affy Says Q4 Revenue Will Fall 11.5 Percent As It Delays 1M SNP Set Launch Three Months | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Affymetrix this week said it expects fourth-quarter revenue to decline around 11.5 percent as it begins a limited launch of its single-chip SNP 5.0 array but delays by around three months the release of its two-chip, 1 million SNP product.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.